2012
DOI: 10.1038/nrurol.2012.84
|View full text |Cite
|
Sign up to set email alerts
|

LASP-1—a promising urine marker for detection of bladder cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 1 publication
1
3
0
Order By: Relevance
“…Our results taken together with these previous observations suggest that higher expression of LASP-1 is involved in the development of metastatic phenotype. This is supported by the recent observation that LASP-1 can be a promising urinary marker for detection of bladder cancer (13,14).…”
Section: Discussionsupporting
confidence: 57%
See 1 more Smart Citation
“…Our results taken together with these previous observations suggest that higher expression of LASP-1 is involved in the development of metastatic phenotype. This is supported by the recent observation that LASP-1 can be a promising urinary marker for detection of bladder cancer (13,14).…”
Section: Discussionsupporting
confidence: 57%
“…Several groups reported that overexpression of LASP-1 has been observed in a variety of malignant tumors including metastatic breast cancer (10), ovarian cancer (11) and medulloblastoma (12). Recent clinical studies have demonstrated that LASP is one of the useful biomarkers for bladder cancer detection (13,14) and that LASP-1 is involved in bladder cancer metastasis (15). The above studies on the LASP-1 function and its high expression in malignant bladder cancer led us to postulate that LASP-1 is involved in bladder cancer malignant phenotypes such as cell invasion through the regulation of actin cytoskeleton.…”
Section: Introductionmentioning
confidence: 99%
“…genecards.org/cgi-bin/carddisp.pl?gene=LASP1, accessed on 10 October 2022). Since then, several authors have studied LASP1 expression, at the mRNA or protein level, in different cancer types [2][3][4][5][6][7][8], reporting that its overexpression is inversely correlated with poor prognosis in breast and prostate cancer, medulloblastoma and hepatocellular carcinoma (HCC). Concerning HCC, we have previously shown that LASP1 mRNA is significantly overexpressed in HCC tissues, mainly in HCC developed in cirrhotic liver, and that levels of LASP1 protein and mRNA expression are comparable and increase in recurrent HCC [9].…”
Section: Introductionmentioning
confidence: 99%
“…LIM and SH3 protein 1 (Lasp-1) is a specific focal adhesion protein that serves an important role in the regulation of cell proliferation and migration ( 6 , 7 ). It has been reported to be upregulated in a number of malignant tumors, including clear cell renal ( 8 ), non-small cell lung ( 9 ), prostate ( 10 ), gallbladder ( 11 ), bladder ( 12 , 13 ), breast ( 14 ), hepatocellular ( 15 , 16 ) and colorectal ( 17 , 18 ) carcinomas. The role of Lasp-1 in metastasis and progression of colorectal carcinomas has been suggested previously ( 17 ).…”
Section: Introductionmentioning
confidence: 99%